When does Itamar Medical Ltd (ITMR) report earnings?
Itamar Medical Ltd (ITMR) will report earnings on 2022-03-01, before the market open.
Itamar Medical Ltd (ITMR) Forecast, Price Target & Analyst Ratings
NASDAQ:ITMR
Current stock price
30.87
+0.25 (+0.82%)
At close:
30.85
-0.02 (-0.06%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Itamar Medical Ltd (ITMR).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $30.87 to mean target of $0.00, Based on 12 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.00%
ITMR was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ITMR.
In the previous month the buy percentage consensus was at a similar level.
ITMR was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-09-20 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2021-09-15 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2021-09-14 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2021-09-14 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 1, 2022
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 24.189M 16.85% | 31.258M 29.22% | 41.034M 31.28% | |
| EBITDA YoY % growth | -2.64M 48.45% | -3.448M -30.61% | -8.526M -147.27% | |
| EBIT YoY % growth | -3.121M 44.56% | -4.894M -56.81% | -10.344M -111.36% | |
| Operating Margin | -12.90% | -15.66% | -25.21% | |
| EPS YoY % growth | N/A | N/A | N/A |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
Itamar Medical Ltd / ITMR Forecast FAQ
Can you provide the consensus rating for Itamar Medical Ltd stock?
The consensus rating for Itamar Medical Ltd (ITMR) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.